The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 499.00
Bid: 492.00
Ask: 506.00
Change: -6.00 (-1.19%)
Spread: 14.00 (2.846%)
Open: 505.00
High: 505.00
Low: 499.00
Prev. Close: 505.00
W7L Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Covid-19 Update and Notice of Results

9 Apr 2020 07:00

RNS Number : 2810J
Warpaint London PLC
09 April 2020
 

9 April 2020

 

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

 

Covid-19 Update and Notice of Results

 

Warpaint London plc (AIM: W7L), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands, provides a further update on the impact of Covid-19 on the Group.

 

Current Trading and Covid-19 Mitigating Actions

 

Prior to the Covid-19 lockdowns, the Group's current year trading to the end of February 2020 was at the upper end of the board's expectations. However, since the Company's last trading update announced on 19 March 2020, there has, as anticipated, been a substantial reduction in Group sales as a result of the lockdowns causing the closure of many of the Group's customer's retail outlets in the UK and its other markets. As a result, most customers are currently reducing, deferring or cancelling orders of all year round cosmetics. The Company continues to sell online and through those retail outlets stocking the Group's products that remain open.

 

In order to mitigate the impact of this, as far as possible, the Group has undertaken a number of significant cost cutting measures which include reducing non-essential spend, furloughing 84 of the Group's 115 UK staff whilst maintaining their salaries and participating in the UK Government's Coronavirus Job Retention Scheme, landlords agreeing to defer rental payments, and the suspension of all marketing, travel and other discretionary expenditure. Staff who have not been furloughed are primarily working on the Group's 2020 Christmas order book, which continues to build.

 

Outlook and Dividend

 

Given the ongoing uncertainty regarding the duration of the Covid-19 outbreak, the board is unable to provide guidance as to the financial outcome for the year ending 31 December 2020. Whilst it anticipates a significant fall in revenue in the current financial year, the board believes that, even if the current lockdown measures were to remain in place until the end of the year, the Group has the financial strength to withstand a disruption to its activities until at least the end of 2020 without the need to seek any additional funding. At 8 April 2020, the Company had cash of £3.3 million and hire purchase and term debt of approximately £500,000.

 

As announced on 6 February 2020, subject to audit, the Company expects to report revenue of £49.3 million and adjusted profit before tax (excluding amortisation in connection with acquisitions, share incentive scheme costs and exceptional items, which the board expects to total approximately £2.8 million) of £5.2 million for the year ended 31 December 2019. The board, under ordinary circumstances, would have sought to maintain its progressive dividend policy, but, in the interests of prudence given the considerable on-going uncertainty, and in order to further preserve the Company's cash resources, the board has resolved to not recommend a final dividend for the year ended 31 December 2019.

 

With the cost cutting measures undertaken and the Group's current financial resources, the directors believe that the Group is well placed to weather the Covid-19 crisis and is well positioned to take advantage of any improvement in market conditions.

 

Notice of Results

 

The Company will provide a further update at the time of announcing its results for the year ended 31 December 2019 which is now expected to be on 13 May 2020.

 

Commenting, Sam Bazini, Chief Executive of Warpaint, said:

 

"The wellbeing and health of our employees is of paramount importance and we are doing everything possible to support them and to ensure that they are well protected in these difficult times.

 

"The current situation is challenging, but I am confident that Warpaint with its differentiated product offering, strong balance sheet and ability to react quickly to changes in circumstances is well positioned to withstand the Covid-19 pandemic."

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Enquiries:

Warpaint London

Sam Bazini - Chief Executive Officer

Eoin Macleod - Managing Director

Neil Rodol - Chief Financial Officer

c/o IFC

 

 

Shore Capital (Nominated Adviser and Joint Broker)

Antonio Bossi - Corporate Advisory

Daniel Bush - Corporate Advisory

Fiona Conroy - Corporate Broking

 

 

020 7408 4090

N+1 Singer (Joint Broker)

Shaun Dobson - Corporate Finance

Alex Bond - Corporate Finance

 

020 7496 3000

 

IFC Advisory (Financial PR & IR)

Tim Metcalfe

Graham Herring

Florence Chandler

020 3934 6630

 

 

 

 

Warpaint London plc

 

Warpaint London plc is made up of two divisions.

 

The largest division sells cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to discount retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and the rest of Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, this division supplies white label cosmetics produced for several major high street retailers. The Group also sells cosmetics using the smaller brand names of Man'stuff, Body Collection, Vintage, Outdoor Girl, Very Vegan, Chit Chat, Smooch, Copy Cat and Taxi.

 

The second division trades in close-out and excess stock of other branded cosmetics and fragrances from around the world.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDBLGDSLSGDGGI
Date   Source Headline
8th Sep 20222:06 pmRNSSecond Price Monitoring Extn
8th Sep 20222:00 pmRNSPrice Monitoring Extension
8th Sep 202211:05 amRNSSecond Price Monitoring Extn
8th Sep 202211:00 amRNSPrice Monitoring Extension
8th Sep 20227:00 amRNSTrading Update
1st Sep 20227:00 amRNSNotice of Results and Investor Webinar
29th Jun 20227:00 amRNSPMDR / PCA Dealing
28th Jun 20227:00 amRNSDirector/PDMR Dealing
27th Jun 202211:34 amRNSResult of AGM
27th Jun 20227:00 amRNSAGM Statement
31st May 20227:00 amRNSNotice of AGM and Posting of Annual Report
26th Apr 20223:57 pmRNSDividend Timetable
26th Apr 20227:00 amRNSResults for the year ended 31 December 2021
12th Apr 20227:00 amRNSTrading Update and Notice of Results
21st Mar 20221:21 pmRNSHolding(s) in Company
11th Mar 20225:23 pmRNSPMDR / PCA Dealing
2nd Mar 20227:00 amRNSWard & Hagon Contract Renewal and Grant of Options
28th Feb 20224:29 pmRNSHolding(s) in Company
23rd Feb 20224:56 pmRNSHolding(s) in Company
1st Feb 20227:00 amRNSFull Year Trading Update
2nd Nov 20217:00 amRNSTrading Update
22nd Sep 20217:00 amRNSInterim Results
16th Sep 202112:16 pmRNSPrice Monitoring Extension
14th Sep 20219:05 amRNSSecond Price Monitoring Extn
14th Sep 20219:00 amRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSNotice of Results & Investor Webinar
3rd Aug 20217:00 amRNSAppointment of Non-Executive Director
11th Jun 202111:24 amRNSResult of AGM
11th Jun 202111:05 amRNSSecond Price Monitoring Extn
11th Jun 202111:00 amRNSPrice Monitoring Extension
11th Jun 20217:00 amRNSAGM Statement
28th May 202111:01 amRNSTotal Voting Rights
25th May 20213:28 pmRNSGrant of Options and Director/PDMR Shareholding
17th May 202112:34 pmRNSNotice of AGM and Posting of Annual Report
6th May 20213:57 pmRNSExercise of share options, issue of equity and TVR
28th Apr 20217:00 amRNSResults for the year ended 31 December 2020
20th Apr 20214:41 pmRNSSecond Price Monitoring Extn
20th Apr 20214:36 pmRNSPrice Monitoring Extension
20th Apr 20217:00 amRNSTrading Update and Notice of Results
19th Apr 20212:26 pmRNSHolding(s) in Company
8th Mar 20214:37 pmRNSHolding(s) in Company
19th Feb 20217:00 amRNSWard & Hagon Contract Renewal
10th Feb 20212:56 pmRNSHolding(s) in Company
22nd Jan 20214:00 pmRNSTransfer of Shares and Director/PDMR Shareholding
18th Jan 20217:00 amRNSFull Year Trading Update
10th Dec 20203:03 pmRNSHolding(s) in Company
17th Nov 20207:00 amRNSUK Retail Update
23rd Sep 20207:00 amRNSInterim Results
4th Sep 20207:00 amRNSNotice of Results
16th Jul 20207:00 amRNSChange of Advisers

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.